| |
| |
|
| Insider
Information: |
Simpson Curran |
| Relationship: |
|
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
123,327 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,769,742 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
123,327 |
|
|
| Total
Value |
$1,769,742 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Human Genome Sciences Inc |
HGSI |
Sr. VP, Operations |
2012-07-30 |
0 |
2007-03-10 |
0 |
Premium* |
|
|
Regenxbio Inc. |
RGNX |
|
2024-01-02 |
123,327 |
2016-12-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2009-08-06 |
4 |
S |
$14.55 |
$1,298,329 |
D/D |
(88,955) |
11,112 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-03-13 |
4 |
S |
$33.00 |
$825,000 |
D/D |
(25,000) |
39,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-12-09 |
4 |
S |
$43.40 |
$680,248 |
D/D |
(15,552) |
23,948 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2009-08-06 |
4 |
OE |
$4.92 |
$584,895 |
D/D |
81,534 |
100,067 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2009-11-30 |
4 |
OE |
$9.78 |
$361,107 |
D/D |
36,923 |
48,035 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-01-11 |
4 |
OE |
$10.89 |
$381,150 |
D/D |
35,000 |
46,112 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-02-16 |
4 |
OE |
$12.38 |
$371,400 |
D/D |
30,000 |
41,112 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-04-12 |
4 |
OE |
$10.89 |
$326,700 |
D/D |
30,000 |
55,281 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-06-11 |
4 |
OE |
$9.78 |
$180,549 |
D/D |
18,461 |
43,742 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-08-25 |
4 |
OE |
$9.78 |
$180,549 |
D/D |
18,461 |
43,742 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2010-10-01 |
4 |
OE |
$12.56 |
$287,662 |
D/D |
22,903 |
48,184 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-04-29 |
4 |
OE |
$9.78 |
$343,825 |
D/D |
28,015 |
73,805 |
0 |
- |
|
| HGSI |
Human Genome Sciences Inc |
Sr. VP, Operations |
• – – |
2011-06-01 |
4 |
OE |
$12.56 |
$287,674 |
D/D |
22,904 |
68,694 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-11-27 |
4 |
OE |
$13.09 |
$26,180 |
D/D |
2,000 |
41,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-04 |
4 |
OE |
$13.09 |
$1,440 |
D/D |
110 |
39,610 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-07 |
4 |
OE |
$13.09 |
$464,740 |
D/D |
21,890 |
61,390 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2017-12-22 |
4 |
OE |
$22.00 |
$660,000 |
D/D |
30,000 |
69,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-03-13 |
4 |
OE |
$22.00 |
$550,000 |
D/D |
25,000 |
64,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-10-16 |
4 |
OE |
$13.09 |
$1,314,223 |
D/D |
62,309 |
42,167 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Technical Operations |
• – – |
2018-11-16 |
4 |
OE |
$22.00 |
$723,404 |
D/D |
32,882 |
72,382 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-05 |
4 |
OE |
$13.09 |
$1,070,658 |
D/D |
43,832 |
83,332 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-02-25 |
4 |
OE |
$35.80 |
$189,740 |
D/D |
5,300 |
44,800 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2019-05-28 |
4 |
OE |
$22.00 |
$396,000 |
D/D |
18,000 |
57,500 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-05 |
4 |
OE |
$13.09 |
$92,886 |
D/D |
5,137 |
28,285 |
0 |
- |
|
| RGNX |
Regenxbio Inc. |
SVP, Product Development & CTO |
• – – |
2020-02-10 |
4 |
OE |
$19.50 |
$858,098 |
D/D |
31,660 |
54,308 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
